Beetham Thomas W. 4/A

What Happened

• Thomas W. Beetham, Chief Operating Officer of Viridian Therapeutics (VRDN), had 3,048 shares withheld/sold to cover taxes related to an option exercise. The shares were disposed at $30.19 each for total proceeds of approximately $92,019. This Form 4 is an amendment correcting the number of shares and price sold to cover taxes and the resulting beneficial ownership reported earlier.

Key Details

• Transaction date: 2026-03-03
• Action/code: F — payment of exercise price or tax liability (sell-to-cover withholding)
• Shares disposed: 3,048 at $30.19 per share; total ≈ $92,019
• Filing: Amended Form 4 (footnote states it corrects prior March 4, 2026 filing numbers and resulting beneficial ownership)
• Resulting shares beneficially owned: updated in the amended filing (see the Form 4 for the corrected total)
• Timeliness: not indicated as late in the provided details

Context

• This was a routine sell-to-cover transaction to satisfy tax withholding from an option exercise (common after exercising stock options). Such withholding sales are administrative and do not necessarily signal the insider’s view on the company’s prospects.